Food and Drug Administration (FDA) for the treatment of irritability associated with autism in children and adolescents aged 5 to 16, Risperidone helps manage aggression, self-injurious behavior, and temper tantrums
Well match you with an in-network expert conveniently located near you or available for virtual appointments
Cerri, S., Mus, L
protect from light and moisture Contraindications & Handling Warnings For licensed research institutions and professionals only Do not inject or consume under any circumstances Avoid contact with skin, eyes, or mucous membranes Use appropriate PPE (personal protective equipment) when handling Dispose of unused material in compliance with local regulations Quality Assurance Produced in a cGMP-compliant facility in the USA Subjected to independent laboratory testing for identity, potency, and purity Certificate of Analysis (CoA) available upon request for research verification FDA Disclaimer This product is not approved by the United States Food and Drug Administration (FDA)
Until then, give yourself a leg up (or liver) by consulting your doctor about treatments through diet, exercise, and underlying condition management
Current evidence suggests minimal infant exposure, but many clinicians recommend waiting until breastfeeding ends or switching to formula if starting GLP-1 treatment
